Literature DB >> 20581439

Lamin A precursor induces barrier-to-autointegration factor nuclear localization.

Cristina Capanni1, Vittoria Cenni, Tokuko Haraguchi, Stefano Squarzoni, Stefan Schüchner, Egon Ogris, Giuseppe Novelli, Nadir Maraldi, Giovanna Lattanzi.   

Abstract

Lamin A, a protein component of the nuclear lamina, is synthesized as a precursor named prelamin A, whose multi-step maturation process involves different protein intermediates. As demonstrated in laminopathies such as familial partial lipodystrophy, mandibuloacral dysplasia, Werner syndrome, Hutchinson-Gilford progeria syndrome and restrictive dermopathy, failure of prelamin A processing results in the accumulation of lamin A protein precursors inside the nucleus which dominantly produces aberrant chromatin structure. To understand if nuclear lamina components may be involved in prelamin A chromatin remodeling effects, we investigated barrier-to-autointegration factor (BAF) localization and expression in prelamin A accumulating cells. BAF is a DNA-binding protein that interacts directly with histones, lamins and LEM-domain proteins and has roles in chromatin structure, mitosis and gene regulation. In this study, we show that the BAF heterogeneous localization between nucleus and cytoplasm observed in HEK293 cycling cells changes in response to prelamin A accumulation. In particular, we observed that the accumulation of lamin A, non-farnesylated prelamin A and farnesylated carboxymethylated lamin A precursors induce BAF nuclear translocation. Moreover, we show that the treatment of human fibroblasts with prelamin A interfering drugs results in similar changes. Finally, we report that the accumulation of progerin, a truncated form of farnesylated and carboxymethylated prelamin A identified in Hutchinson-Gilford progeria syndrome cells, induces BAF recruitment in the nucleus. These findings are supported by coimmunoprecipitation of prelamin A or progerin with BAF in vivo and suggest that BAF could mediate prelamin A-induced chromatin effects.
© 2010 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581439     DOI: 10.4161/cc.9.13.12080

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

Review 1.  Progeria: A Rare Genetic Syndrome.

Authors:  Veena Sharma; Richa Shukla
Journal:  Indian J Clin Biochem       Date:  2019-09-25

Review 2.  Barrier to Autointegration Factor (BANF1): interwoven roles in nuclear structure, genome integrity, innate immunity, stress responses and progeria.

Authors:  Augusta Jamin; Matthew S Wiebe
Journal:  Curr Opin Cell Biol       Date:  2015-06-10       Impact factor: 8.382

3.  HIV-1 viral protein R downregulates Ebp1 and stabilizes p53 in glioblastoma U87MG cells.

Authors:  S Zhang; B Zhang; X Xu; L Wang; X Feng; Q Wang; H Huang; J Wu; P Li; J Wang
Journal:  Clin Transl Oncol       Date:  2013-07-05       Impact factor: 3.405

4.  Nuclear envelope proteins modulate proliferation of vascular smooth muscle cells during cyclic stretch application.

Authors:  Ying-Xin Qi; Qing-Ping Yao; Kai Huang; Qian Shi; Ping Zhang; Guo-Liang Wang; Yue Han; Han Bao; Lu Wang; Hai-Peng Li; Bao-Rong Shen; Yingxiao Wang; Shu Chien; Zong-Lai Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

Review 5.  Diverse cellular functions of barrier-to-autointegration factor and its roles in disease.

Authors:  Rhiannon M Sears; Kyle J Roux
Journal:  J Cell Sci       Date:  2020-08-17       Impact factor: 5.285

6.  Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution.

Authors:  Cristina Capanni; Stefano Squarzoni; Vittoria Cenni; Maria Rosaria D'Apice; Alessandra Gambineri; Giuseppe Novelli; Manfred Wehnert; Renato Pasquali; Nadir M Maraldi; Giovanna Lattanzi
Journal:  Cell Cycle       Date:  2012-08-30       Impact factor: 4.534

7.  Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies.

Authors:  G Lattanzi; S Benedetti; E Bertini; G Boriani; L Mazzanti; G Novelli; R Pasquali; A Pini; L Politano
Journal:  Acta Myol       Date:  2011-10

8.  Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria.

Authors:  V Cenni; C Capanni; M Columbaro; M Ortolani; M R D'Apice; G Novelli; M Fini; S Marmiroli; E Scarano; N M Maraldi; S Squarzoni; S Prencipe; G Lattanzi
Journal:  Eur J Histochem       Date:  2011-10-19       Impact factor: 3.188

9.  Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins.

Authors:  Camilla Evangelisti; Pia Bernasconi; Paola Cavalcante; Cristina Cappelletti; Maria Rosaria D'Apice; Paolo Sbraccia; Giuseppe Novelli; Sabino Prencipe; Silvia Lemma; Nicola Baldini; Sofia Avnet; Stefano Squarzoni; Alberto M Martelli; Giovanna Lattanzi
Journal:  Oncotarget       Date:  2015-04-10

Review 10.  Muscle development, regeneration and laminopathies: how lamins or lamina-associated proteins can contribute to muscle development, regeneration and disease.

Authors:  Magda Dubinska-Magiera; Magdalena Zaremba-Czogalla; Ryszard Rzepecki
Journal:  Cell Mol Life Sci       Date:  2012-11-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.